Tissue at risk in acute stroke patients treated beyond 8 h after symptom onset

Neuroradiology

Volumn 55, Issue 7, 2013, Pages 807-812

  Leiva Salinas, C ^a,b   Aghaebrahim, A ^c   Zhu, G ^a,d   Patrie, J T ^a   Xin, W ^a   Lau, B C ^a   Jovin, T ^c   Wintermark, M ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

CT; Infarction; MRI; Stroke; Thrombolytics

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST;

ADULT; AGED; ANGIOPLASTY; ARTICLE; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MECHANICAL THROMBECTOMY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RANKIN SCALE; STENT;

EID: 84880783225     PISSN: 00283940     EISSN: 14321920     Source Type: Journal    
DOI: 10.1007/s00234-013-1164-7     Document Type: Article

References (21)

1. Bambauer KZ, Johnston SC, Bambauer DE, Zivin JA (2006) Reasons why few patients with acute stroke receive tissue plasminogen activator. Arch Neurol 63:661-664
2. Hacke W, Kaste M, Bluhmki E et al (2008) Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359:1317-1329
3. Copen WA, Rezai Gharai L, Barak ER et al (2009) Existence of the diffusion-perfusion mismatch within 24 hours after onset of acute stroke: dependence on proximal arterial occlusion. Radiology 250:878-886
4. Read SJ, Hirano T, Abbott DF et al (2000) The fate of hypoxic tissue on 18F-fluoromisonidazole positron emission tomography after ischemic stroke. Ann Neurol 48:228-235
5. Read SJ, Hirano T, Abbott DF et al (1998) Identifying hypoxic tissue after acute ischemic stroke using PET and 18F-fluoromisonidazole. Neurology 51:1617-1621
6. Albers GW, Thijs VN, Wechsler L et al (2006) Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 60:508-517
7. Furlan AJ, Eyding D, Albers GW et al (2006) Dose escalation of desmoteplase for acute ischemic stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 37:1227-1231
8. Hacke W, Albers G, Al-Rawi Y et al (2005) The desmoteplase in acute ischemic stroke trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 36:66-73
9. Lees KR, Bluhmki E, von Kummer R et al (2010) Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 375:1695-1703
10. Saver JL, Levine SR (2010) Alteplase for ischaemic stroke - much sooner is much better. Lancet 375:1667-1668
11. Khatri P, Abruzzo T, Yeatts SD et al (2009) Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology 73:1066-1072
12. Zangerle A, Kiechl S, Spiegel M et al (2007) Recanalization after thrombolysis in stroke patients: predictors and prognostic implications. Neurology 68:39-44
13. Kidwell CS, Alger JR, Saver JL (2003) Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. Stroke 34:2729-2735
14. Abou-Chebl A (2010) Endovascular treatment of acute ischemic stroke may be safely performed with no time window limit in appropriately selected patients. Stroke 41:1996-2000
15. Jovin TG, Liebeskind DS, Gupta R et al (2011) Imaging-based endovascular therapy for acute ischemic stroke due to proximal intracranial anterior circulation occlusion treated beyond 8 hours from time last seen well: retrospective multicenter analysis of 237 consecutive patients. Stroke 42:2206-2211
16. Furlan A, Higashida R, Wechsler L et al (1999) Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 282:2003-2011
17. Jovin TG, Yonas H, Gebel JM et al (2003) The cortical ischemic core and not the consistently present penumbra is a determinant of clinical outcome in acute middle cerebral artery occlusion. Stroke 34:2426-2433
18. Rha JH, Saver JL (2007) The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke 38:967-973
19. Poisson SN, Nguyen-Huynh MN, Johnston SC, Furie KL, Lev MH, Smith WS (2011) Intracranial large vessel occlusion as a predictor of decline in functional status after transient ischemic attack. Stroke 42:44-47
20. Smith WS, Lev MH, English JD et al (2009) Significance of large vessel intracranial occlusion causing acute ischemic stroke and TIA. Stroke 40:3834-3840
21. Rosso C, Colliot O, Valabrègue R et al (2011) Tissue at risk in the deep middle cerebral artery territory is critical to stroke outcome. Neuroradiology 53:763-71